Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.1K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.1K
Proteoglycans01:05

Proteoglycans

4.1K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.1K
Glycosaminoglycans01:23

Glycosaminoglycans

5.6K
Glycosaminoglycans (GAGs), also known as mucopolysaccharides, are long and linear polymers comprising of specific repeating disaccharides - the amino sugar that can be N-acetylglucosamine or N-acetylgalactosamine, and a uronic acid that is usually glucuronic acid or iduronic acid.
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
5.6K
Protein Glycosylation01:25

Protein Glycosylation

8.0K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
8.0K
Oligosaccharide Assembly01:24

Oligosaccharide Assembly

3.1K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
3.1K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

447
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
447

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case Report: Exceptional longevity in turner syndrome.

Frontiers in aging·2026
Same author

Distinct post-infectious TLR2 immune remodeling in COVID-19-recovered centenarians.

Mechanisms of ageing and development·2026
Same author

iPSC-derived skeletal muscle spheroids for Duchenne Muscular Dystrophy modeling.

Skeletal muscle·2026
Same author

Comparative evaluation of an original microhaplotype panel and its expanded version for human identification and ancestry inference in Brazilian and admixed American populations.

Forensic science international. Genetics·2026
Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Rare Duplication in the <i>RYR1</i> Gene Causing Malignant Hyperthermia and Clinical Variability.

Genes·2025
Same journal

Aquatic training improves muscle strength and functional mobility in adults with myotonic dystrophy type 1: a pilot randomized trial.

Neuromuscular disorders : NMD·2026
Same journal

Severe dilated cardiomyopathy in females with dystrophinopathy : a case series of nine patients.

Neuromuscular disorders : NMD·2026
Same journal

A portrait of facioscapulohumeral muscular dystrophy through history: past milestones and future challenges on the road to understanding and treatment.

Neuromuscular disorders : NMD·2026
Same journal

Systematic review of outcome measures in facioscapulohumeral dystrophy (FSHD): validated, usable, and feasible tools for assessing function, performance, and strength.

Neuromuscular disorders : NMD·2026
Same journal

Longitudinal functional trajectories in Duchenne muscular dystrophy: outcome-specific patterns from a registry-based modelling study.

Neuromuscular disorders : NMD·2026
Same journal

HACD1-related congenital myopathy skeletal muscle MRI findings in a Brazilian cohort.

Neuromuscular disorders : NMD·2026
See all related articles

Related Experiment Video

Updated: Oct 23, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.8K

Sarcoglycanopathies: an update.

Mariz Vainzof1, Lucas S Souza1, Juliana Gurgel-Giannetti2

  • 1Human Genome and Stem Cell Research Center, Department of Genetics and Evolutionary Biology, Biosciences Institute, University of São Paulo, São Paulo, Brazil.

Neuromuscular Disorders : NMD
|August 18, 2021
PubMed
Summary
This summary is machine-generated.

Sarcoglycanopathies, severe muscular dystrophies, involve mutations in sarcoglycan genes. Gene replacement therapy shows promise in preclinical models, with human trials underway.

Keywords:
DMD-likeDystrophin-glycoprotein complexLimb girdle muscular dystrophiesSCARMDSarcoglycanopathies

More Related Videos

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
07:45

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

8.1K
Cell Membrane Repair Assay Using a Two-photon Laser Microscope
06:35

Cell Membrane Repair Assay Using a Two-photon Laser Microscope

Published on: January 2, 2018

12.9K

Related Experiment Videos

Last Updated: Oct 23, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.8K
An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
07:45

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

8.1K
Cell Membrane Repair Assay Using a Two-photon Laser Microscope
06:35

Cell Membrane Repair Assay Using a Two-photon Laser Microscope

Published on: January 2, 2018

12.9K

Area of Science:

  • Genetics and Molecular Biology
  • Neurology
  • Biochemistry

Background:

  • Sarcoglycanopathies are severe autosomal recessive limb-girdle muscular dystrophies (LGMDs), accounting for 10-25% of LGMD cases.
  • Characterized by early onset, muscle hypertrophy, elevated creatine kinase (CK), progressive weakness, and ambulation loss.
  • Four subtypes (LGMDR3-R6) result from mutations in SGCA, SGCB, SGCG, and SGCD genes, affecting sarcoglycan proteins essential for sarcolemma integrity.

Purpose of the Study:

  • To review the genetic basis, clinical presentation, and diagnostic approaches for sarcoglycanopathies.
  • To discuss current therapeutic strategies, focusing on gene replacement therapy using adeno-associated virus (AAV) vectors.
  • To highlight the progress and ongoing status of therapeutic trials for sarcoglycanopathies.

Main Methods:

  • Review of existing literature on sarcoglycanopathies.
  • Analysis of genetic mutations and their impact on sarcoglycan protein function.
  • Evaluation of preclinical and clinical data for gene replacement therapy.

Main Results:

  • Identification of four subtypes of sarcoglycanopathies caused by mutations in specific sarcoglycan genes.
  • Demonstration of the role of sarcoglycan proteins within the dystrophin-glycoprotein complex (DGC) in maintaining muscle sarcolemma stability.
  • Preclinical studies show successful restoration of sarcoglycan protein levels and phenotypic improvement in animal models.

Conclusions:

  • Sarcoglycanopathies represent a significant group of LGMDs with a defined genetic basis and clinical progression.
  • Molecular screening is crucial for diagnosis.
  • Gene replacement therapy using AAV vectors is a promising therapeutic avenue, with ongoing human trials.